Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Transplantation Proceedings|March 14, 2025
Successful Liver Transplantation After Achieving Complete Clinical Remission of Hepatocellular Carcinoma With Combination Therapy of Immune Checkpoint Inhibitors and Targeted Agents: A Case ReportShaobo Zhang, Shugeng Zhang
Cancer Immunology, Immunotherapy : CII|May 19, 2025
Biomarker, efficacy and safety analysis of transcatheter arterial chemoembolization combined with atezolizumab and bevacizumab for unresectable hepatocellular carcinomaShaobo Zhang, Zebin Zhu, Lianxin Liu, et al.
Cell Death & Disease|August 31, 2021
LncRNA coordinates Hippo and mTORC1 pathway activation in cancerShugeng Zhang, Shuhang Liang, Dehai Wu, et al.
Transplantation Proceedings|February 10, 2026
A Case Report of Posterior Reversible Encephalopathy Syndrome With Intracranial Hemorrhage After Split-Liver TransplantationJiancheng Wu, Jiwei Qin, Xiaodong Yuan, et al.
Transplantation Proceedings|May 30, 2024
Liver Transplantation for Diffuse Form of Caroli Disease with Chronic Hepatitis B: A Case ReportYafei Guo, Shilan Li, Zebin Zhu, et al.
Aging and Disease|May 16, 2023
Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer's Disease and Parkinson's DiseaseJing Yang, Wei Zhang, Shugeng Zhang, et al.
Frontiers in Genetics|February 17, 2022
Downregulation of MARC2 Promotes Immune Escape and Is Associated With Immunosuppression of Hepatocellular CarcinomaDehai Wu, Shuhang Liang, Hongrui Guo, et al.
Journal of Hepatocellular Carcinoma|September 8, 2025
Efficacy and Safety of Different Doses of Bevacizumab Combined with Atezolizumab in Unresectable Hepatocellular CarcinomaShaobo Zhang, Jiabei Wang, Zebin Zhu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 14, 2020
Clinical characteristics and management of 1572 patients with pyogenic liver abscess: A 12-year retrospective studyDalong Yin, Changyong Ji, Shugeng Zhang, et al.
Cancer Letters|May 8, 2025
Glycolytic enzyme PFKFB4 governs lipolysis by promoting de novo lipogenesis to drive the progression of hepatocellular carcinomaShuo Zhou, Yao Liu, Ning Zhang, et al.
Pageof 4